Address
Other Office
10956 Weyburn Avenue
Suite 222
Los Angeles, CA 90024
United States
Phone
Website
Recent investment activity
KANDO id: 2842
Corporate information
Also known as
Research Corporation Technologies BioVentures
Registration country
Company type
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companiesRelation
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 40| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
VasoNova Inc | Leader in algorithm-based vascular navigation and measurement technology. | Series B | |||
|
|
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series C Initial investment | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B Initial investment | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | |||
|
|
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series A Initial investment | |||
|
|
VasoNova Inc | Leader in algorithm-based vascular navigation and measurement technology. | N/A | |||
|
|
LaCoste & Romberg Scintrex Inc | N/A Initial investment | ||||
|
|
Fullerene International Corp | N/A | ||||
|
|
Lacoste & Romberg-Scintrex Inc | N/A | ||||
|
|
NP Photonics Inc | N/A | ||||
|
|
OncoGenex Pharmaceuticals | A biopharmaceutical company committed to the development and commercialization of new cancer therapies. | N/A Initial investment | |||
|
|
ParinGenix Inc | N/A Initial investment | ||||
|
|
Peptech Ltd | N/A Initial investment | ||||
|
|
Sertoli Technologies Inc (STI) | N/A Initial investment | ||||
|
|
Spirogen Ltd | Develops potent small molecules based on novel mechanisms and chemistry in the fight to target important cancers. | N/A Initial investment | |||
|
|
Therapeutic Human Polyclonals Inc (THP) | N/A Initial investment | ||||
|
|
Clear Catheter Systems | N/A Initial investment | ||||
|
|
Kerberos Proximal Solutions Inc | A medical device company that has developed products for improved vascular treatments. | N/A Initial investment | |||
|
|
Option 3 LLC | Medical device development and commercialization company. | N/A Initial investment | |||
|
|
VasoNova Inc | Leader in algorithm-based vascular navigation and measurement technology. | N/A Initial investment | |||
|
|
Fullerene International Corp | N/A Initial investment | ||||
|
|
NP Photonics Inc | N/A Initial investment | ||||
|
|
Varix Medical Corp | Developer of devices for chronic venous insufficiency | N/A | |||
|
|
Peptech Ltd | N/A | ||||
|
|
Jenrin Discovery Inc | Developer of drugs for the treatment of inflammatory and metabolic disorders, including obesity. | N/A Initial investment |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Paul Grand | [email protected] | |||
| Shaun Kirkpatrick | [email protected] | |||
| Chad W Souvignier | [email protected] |